Safety, Tolerability, Pharmacokinetics, and Acceptability of Oral and Long-Acting Cabotegravir in HIV-Negative Chinese Men

Long-acting (LA) cabotegravir demonstrated superior efficacy versus daily oral standard-of-care for HIV-1 preexposure prophylaxis. This phase 1 study assessed safety, tolerability, pharmacokinetics, and acceptability of cabotegravir in 47 HIV-negative adult Chinese men at low risk of acquiring HIV-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Kelong, Wannamaker, Paul, Lu, Hongzhou, Zhu, Biao, Wang, Meixia, Paff, Melanie, Spreen, William R., Ford, Susan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923182/
https://www.ncbi.nlm.nih.gov/pubmed/35129374
http://dx.doi.org/10.1128/aac.02057-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923182/
https://www.ncbi.nlm.nih.gov/pubmed/35129374
http://dx.doi.org/10.1128/aac.02057-21

Ejemplares similares